Enveric Biosciences Inc vs Stanley Black & Decker, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Stanley Black & Decker, Inc. trades at $104 (market cap $15.71B). The key difference: Stanley Black & Decker, Inc. is far larger — about 2533.9× Enveric Biosciences Inc's market cap, and Stanley Black & Decker, Inc. pays a 3.23% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | SWK | |
|---|---|---|
Market Cap | $6.20M | $15.71B |
Sector | Health | — |
52-Week High | $17.40 | $104.00 |
52-Week Low | $1.27 | $62.12 |
Enterprise Value | $1.30M | $19.87B |
Dividend Yield | — | 3.23% |
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →